meptazinol
Meptazinol, sold under the brand name Meptid, is an opioid analgesic developed by Wyeth in the 1970s. Indications for use in moderate to severe pain, most commonly used to treat pain in obstetrics (childbirth).
Research
244 papers- Meptazinol.Lancet (London, England) · 1983
- Meptazinol.Lancet (London, England) · 1983
- Oral meptazinol--United Kingdom experience.Postgraduate medical journal · 1985
- Meptazinol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.Drugs · 1985
- Asymmetric Total Synthesis of Meptazinol.The Journal of organic chemistry · 2022
via PubMed
Article
2 sectionsContents
- References
- External links
Meptazinol, sold under the brand name Meptid, is an opioid analgesic developed by Wyeth in the 1970s. Indications for use in moderate to severe pain, most commonly used to treat pain in obstetrics (childbirth).
Meptazinol is a 3-phenylazepane derivative, whereas the other phenazepanes like ethoheptazine and proheptazine are 4-phenylazepanes.
Connections
Categories
3-Hydroxyphenyl compoundsAzepanesChemical articles with multiple CAS registry numbersChemical pages without DrugBank identifierChemicals using indexlabelsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsECHA InfoCard ID from WikidataMultiple chemicals in Infobox drugSynthetic opioids